英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

dynasty    音标拼音: [d'ɑɪnəsti]
n. 朝代,王朝

朝代,王朝

dynasty
n 1: a sequence of powerful leaders in the same family

Dynasty \Dy"nas*ty\ (d[imac]"nas*t[y^] or d[i^]n"as*t[y^]; 277),
n.; pl. {Dynasties} (-t[i^]z). [Gr. dynastei`a lordship, fr.
dynastey`ein to hold power or lordship, fr. dyna`sths: cf. F.
dynastie dynasty. See {Dynast}.]
1. Sovereignty; lordship; dominion. --Johnson.
[1913 Webster]

2. A race or succession of kings, of the same line or family;
the continued lordship of a race of rulers.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
dynasty查看　dynasty　在百度字典中的解释百度英翻中〔查看〕
dynasty查看　dynasty　在Google字典中的解释Google英翻中〔查看〕
dynasty查看　dynasty　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Relapsed Refractory Multiple Myeloma: How Treatment Changes - WebMD
    Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement It’s considered to be refractory when it gets worse even though it’s being treated
  • Relapsed and Refractory Multiple Myeloma - StatPearls - NCBI Bookshelf
    According to the criteria developed by the International Myeloma Working Group (IMWG), relapsed refractory MM (RRMM) is defined as a progressive disease, poor response despite treatment, progression within 60 days of the most recent treatment in a patient who had achieved remission, the absence of at least minimal response (MR), or primary
  • Relapsed Refractory Multiple Myeloma: A Review of Available Therapies . . .
    The introduction of immuno-modulatory drugs began with Thalidomide in the late 1990s for relapsed refractory multiple myeloma (RRMM) and revolutionized the treatment options offered to patients A phase II study enrolling 84 RRMM patients led to the eventual approval of Thalidomide with Dexamethasone in 2006 by the FDA to treat both newly
  • Multiple Myeloma Relapse: Rate, Treatment and Life Expectancy
    Refractory relapse treatment Relapsed multiple myeloma might behave differently from the initial disease During each round of treatment, the goal is to kill abnormal cells When almost all the cancer cells are destroyed, patients may undergo tests that show no evidence of disease
  • Refractory Multiple Myeloma: Symptoms, Causes, and Treatment - Healthline
    Myeloma may be classified as either relapsed — if treatment initially worked but then stopped responding, or refractory — if the condition starts progressing despite initial treatment
  • When and How to Treat Relapsed Multiple Myeloma
    Selinexor, belantamab, and venetoclax are exciting new agents for relapsed or refractory myeloma, but perhaps the most promise for high response rates lies with immunotherapy, either as dual-body T-cell engagers or engineered T cells (POM) and dexamethasone (DEX) for the treatment of relapsed refractory multiple myeloma (RRMM) Blood 2020
  • Multiple Myeloma | Relapsed and Refractory Myeloma | LLS
    The treatment for relapsed and refractory myeloma is affected by many factors including previous therapy, rate of relapse, patient health, and genetic abnormalities Treatment for Relapsed and Refractory Myeloma Treatment for relapsed or refractory myeloma may include: A clinical trial;
  • Relapsed refractory multiple myeloma: a comprehensive overview
    Most patients with relapsed refractory multiple myeloma (RRMM) have been treated with drug combinations including a proteasome inhibitor (PI) and or an immunomodulatory drug (IMiD) The goal of
  • How I treat relapsed multiple myeloma Free - American Society of Hematology
    Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group Lancet Oncol 2021; 22 (3): e105-e118 Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed refractory myeloma: a phase I II study Leukemia 2018; 32 (8): 1803-1807
  • Treatment of relapsed and refractory multiple myeloma: recommendations . . .
    This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma Based on the results of phase 2 and phase 3 trials, these recommendations are proposed for the treatment of patients with relapsed and refractory disease who have received one previous line of therapy, and for patients with





中文字典-英文字典  2005-2009